VERA THERAPEUTICS INC (VERA)

US92337R1014 - Common Stock

39.65  +0.96 (+2.48%)

After market: 39.65 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
N/A0.000.000.000.00
Operating Expenses
102.01M90.90M34.40M48.06M11.59M
Research and Development
78.22M68.99M22.48M44.17M7.19M
Selling, General, and Administrative Expenses
23.79M21.91M11.92M3.89M4.41M
Operating Income
-102.01M-90.90M-34.40M-48.06M-11.59M
Interest Income/Expense
N/A760.00K-10.00K-160.00K110.00K
Other Income/Expense
6.02M1.09M-890.00K-1.08M0.00
Non Recurring Items
N/A0.002.69M-4.12M-370.00K
Income Before Taxes
-95.99M-89.06M-32.61M-53.41M-11.85M
Income Tax
1.00K0.000.000.000.00
Net Income
-95.99M-89.06M-32.61M-53.41M-11.85M
EBITDA
N/AN/A-34.22M-47.81M-11.08M
 
Per Share Data
EPS Diluted Total Ops
-2.25-3.35-1.53-2.61-0.58
Non GAAP EPS
-2.31-3.35-13.71N/AN/A
 
Statistics

All data in USD

Charts